Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Organovo Holdings Inc

ONVO
Current price
0.4 USD -0.021 USD (-5.06%)
Last closed 0.43 USD
ISIN US68620A2033
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 7 276 496 USD
Yield for 12 month -70.25 %
1Y
3Y
5Y
10Y
15Y
ONVO
21.11.2021 - 28.11.2021

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company's lead candidate is FXR314, which is phase 2/3clinical trial for indication of inflammatory bowel disease with a clinical focus on ulcerative colitis; and completed phase 1 clinical trial for the indication of liver fibrosis with a clinical focus steatohepatitis. Organovo Holdings, Inc. has research collaborations with Yale School of Medicine, Knight Cancer Institute at Oregon Health & Science University, and the University of Virginia for research of NovoGen Bioprinters. The company was incorporated in 2007 and is headquartered in San Diego, California. Address: 11555 Sorrento Valley Road, San Diego, CA, United States, 92121

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6.1 USD

P/E ratio

Dividend Yield

Current Year

+109 000 USD

Last Year

+370 000 USD

Current Quarter

+39 000 USD

Last Quarter

+29 000 USD

Current Year

-171 000 USD

Last Year

+77 000 USD

Current Quarter

-33 000 USD

Last Quarter

-41 000 USD

Key Figures ONVO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -13 994 000 USD
Operating Margin TTM -8682.05 %
PE Ratio
Return On Assets TTM -73.67 %
PEG Ratio
Return On Equity TTM -151.72 %
Wall Street Target Price 6.1 USD
Revenue TTM 73 000 USD
Book Value 0.46 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -48 %
Dividend Yield
Gross Profit TTM -8 515 000 USD
Earnings per share -1.28 USD
Diluted Eps TTM -1.28 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ONVO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ONVO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 19.08.2020
Dividend Date 19.08.2020

Stock Valuation ONVO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 30.7275
Price Sales TTM 99.678
Enterprise Value EBITDA -0.3358
Price Book MRQ 1.0725

Financials ONVO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ONVO

For 52 weeks

0.4 USD 2.05 USD
50 Day MA 0.5 USD
Shares Short Prior Month 32 498
200 Day MA 0.8 USD
Short Ratio 0.55
Shares Short 39 070
Short Percent 0.26 %